FDA investigators handed France-based drug manufacturer Merck Sharp & Dohme-Chibret Laboratories a Form 483 after an inspection revealed sterilization issues and drug batch failures were not reported on time.
Source: Drug GMP Report
FDA investigators handed France-based drug manufacturer Merck Sharp & Dohme-Chibret Laboratories a Form 483 after an inspection revealed sterilization issues and drug batch failures were not reported on time.
Source: Drug GMP Report